Welcome to
a new era of mental
health treatment
At Madrigal, we’re harnessing the power of psychedelics to revolutionize the way we address mental health issues. By doing so, we’re able to unlock their potential for healing and bring relief to those suffering from a range of mental health conditions.
The need for innovative and effective mental health treatments has never been greater.
Millions of people around the world are struggling with conditions like depression, PTSD, and other chronic conditions, with many experiencing limited relief from traditional treatments. At Madrigal, we recognize the urgent need for new approaches to mental health care. That’s why we’re committed to exploring the potential of psychedelics, which have shown promise in early research as a safe and effective treatment for a variety of mental health issues. By advancing this field and bringing new treatments to market, we hope to make a real difference in the lives of those struggling with these conditions.
Nanotechnology-Based Psychedelic Treatment for Mental Health
Our innovative solution utilizes biodegradable nanotechnology to improve the accuracy and efficiency of treatments, while also addressing the challenge of crossing the blood-brain barrier. Our technology has been developed over the past five years at Ben Gurion University in Beer Sheva, Israel and is protected by multiple patents. With our cutting-edge approach, we aim to provide more effective and cost-efficient treatments for a variety of medical conditions. Join us as we pave the way for a brighter future in medicine.
Dedicated to revolutionizing the field of drug delivery
Our cutting-edge approach utilizes molecules composed of psychedelic drugs such as psilocybin, ketamine, mescaline, MDMA, and more. By fundamentally changing the coding in the brain, rather than simply treating symptoms, we’re able to offer a transformative solution with minimal side effects. Our innovative technology provides hope for a future where individuals can enjoy a good quality of life without the need for long-term therapy-based treatments.
